301 related articles for article (PubMed ID: 11850718)
21. MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis.
Garvican ER; Vaughan-Thomas A; Redmond C; Clegg PD
Connect Tissue Res; 2008; 49(2):62-7. PubMed ID: 18382891
[TBL] [Abstract][Full Text] [Related]
22. Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model.
Watson Levings RS; Smith AD; Broome TA; Rice BL; Gibbs EP; Myara DA; Hyddmark EV; Nasri E; Zarezadeh A; Levings PP; Lu Y; White ME; Dacanay EA; Foremny GB; Evans CH; Morton AJ; Winter M; Dark MJ; Nickerson DM; Colahan PT; Ghivizzani SC
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):101-112. PubMed ID: 29869535
[TBL] [Abstract][Full Text] [Related]
23. The promise of a new clinical trial--intra-articular IL-1 receptor antagonist.
Evans CH; Robbins PD
Proc Assoc Am Physicians; 1996 Jan; 108(1):1-5. PubMed ID: 8834057
[TBL] [Abstract][Full Text] [Related]
24. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.
van der Laan WH; Quax PH; Seemayer CA; Huisman LG; Pieterman EJ; Grimbergen JM; Verheijen JH; Breedveld FC; Gay RE; Gay S; Huizinga TW; Pap T
Gene Ther; 2003 Feb; 10(3):234-42. PubMed ID: 12571631
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis.
Kim SH; Lechman ER; Kim S; Nash J; Oligino TJ; Robbins PD
Mol Ther; 2002 Nov; 6(5):591-600. PubMed ID: 12409257
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
[TBL] [Abstract][Full Text] [Related]
28. An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint.
van de Loo FA; de Hooge AS; Smeets RL; Bakker AC; Bennink MB; Arntz OJ; Joosten LA; van Beuningen HM; van der Kraan PK; Varley AW; van den Berg WB
Gene Ther; 2004 Apr; 11(7):581-90. PubMed ID: 14973543
[TBL] [Abstract][Full Text] [Related]
29. [Gene therapy for osteoarticular disorders].
Gouze JN; Evans CH; Ghivizzani SC; Gouze E
Med Sci (Paris); 2007 Mar; 23(3):303-9. PubMed ID: 17349293
[TBL] [Abstract][Full Text] [Related]
30. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
Yao Q; Wang S; Gambotto A; Glorioso JC; Evans CH; Robbins PD; Ghivizzani SC; Oligino TJ
Gene Ther; 2003 Jun; 10(12):1055-60. PubMed ID: 12776164
[TBL] [Abstract][Full Text] [Related]
31. Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis.
Geurts J; Arntz OJ; Bennink MB; Joosten LA; van den Berg WB; van de Loo FA
Gene Ther; 2007 Dec; 14(23):1632-8. PubMed ID: 17851546
[TBL] [Abstract][Full Text] [Related]
32. The Marshall R. Urist Young Investigator Award. Orthopaedic applications of gene therapy. From concept to clinic.
Kang R; Ghivizzani SC; Muzzonigro TS; Herndon JH; Robbins PD; Evans CH
Clin Orthop Relat Res; 2000 Jun; (375):324-37. PubMed ID: 10853185
[TBL] [Abstract][Full Text] [Related]
33. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
[TBL] [Abstract][Full Text] [Related]
34. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
Guo WS; Ma L; Li ZR
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
[TBL] [Abstract][Full Text] [Related]
35. IL-1ra/IGF-1 gene therapy modulates repair of microfractured chondral defects.
Morisset S; Frisbie DD; Robbins PD; Nixon AJ; McIlwraith CW
Clin Orthop Relat Res; 2007 Sep; 462():221-8. PubMed ID: 17534189
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy for osteoarthritis: new perspectives for the twenty-first century.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S262-72. PubMed ID: 11039780
[TBL] [Abstract][Full Text] [Related]
37. Microscopic change in macroscopically normal equine cartilage from osteoarthritic joints.
Weaver RE; Sharif M; Livingston LA; Andrews KL; Fuller CJ
Connect Tissue Res; 2006; 47(2):92-101. PubMed ID: 16754515
[TBL] [Abstract][Full Text] [Related]
38. Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure.
McAuliffe PF; Murday ME; Efron PA; Scumpia PO; Ungaro R; Abouhamze A; Tannahill CL; Hutchins B; LaFace D; Moldawer LL
Gene Ther; 2006 Feb; 13(3):276-82. PubMed ID: 16251998
[TBL] [Abstract][Full Text] [Related]
39. Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery.
Agrawal VK; Copeland KM; Barbachano Y; Rahim A; Seth R; White CL; Hingorani M; Nutting CM; Kelly M; Harris P; Pandha H; Melcher AA; Vile RG; Porter C; Harrington KJ
Gene Ther; 2009 Jan; 16(1):78-92. PubMed ID: 18784747
[TBL] [Abstract][Full Text] [Related]
40. IL-1ra gene therapy in equine osteoarthritis improves physiological, anatomical, and biological outcomes of joint degeneration.
Goodrich LR; McIlwraith CW; Grieger J; Kraus VB; Stabler T; Werpy N; Phillips J; Samulski RJ; Frisbie D
J Am Vet Med Assoc; 2024 Jun; 262(S1):S109-S120. PubMed ID: 38631386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
